Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Role of receptor occupancy assays by flow cytometry in drug development.

Stewart JJ, Green CL, Jones N, Liang M, Xu Y, Wilkins DE, Moulard M, Czechowska K, Lanham D, McCloskey TW, Ferbas J, van der Strate BW, Högerkorp CM, Wyant T, Lackey A, Litwin V.

Cytometry B Clin Cytom. 2016 Mar;90(2):110-6. doi: 10.1002/cyto.b.21355. Epub 2016 Feb 16. Review.

2.

Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.

Green CL, Stewart JJ, Högerkorp CM, Lackey A, Jones N, Liang M, Xu Y, Ferbas J, Moulard M, Czechowska K, Mc Closkey TW, van der Strate BW, Wilkins DE, Lanham D, Wyant T, Litwin V.

Cytometry B Clin Cytom. 2016 Mar;90(2):141-9. doi: 10.1002/cyto.b.21339. Epub 2016 Feb 22. Review.

3.

How validated receptor occupancy flow cytometry assays can impact decisions and support drug development.

Moulard M, Ozoux ML.

Cytometry B Clin Cytom. 2016 Mar;90(2):150-8. doi: 10.1002/cyto.b.21320. Epub 2015 Dec 11. Review.

4.

Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors.

Hubertus K, Mischnik M, Timmer J, Herterich S, Mark R, Moulard M, Walter U, Geiger J.

Eur J Pharmacol. 2014 Oct 5;740:15-27. doi: 10.1016/j.ejphar.2014.06.030. Epub 2014 Jul 6.

PMID:
25003953
5.

A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: proof of principle with rituximab and ofatumumab.

Engelberts PJ, Badoil C, Beurskens FJ, Boulay-Moine D, Grivel K, Parren PW, Moulard M.

J Immunol Methods. 2013 Feb 28;388(1-2):8-17. doi: 10.1016/j.jim.2012.11.007. Epub 2012 Nov 24.

PMID:
23183273
6.

Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition.

Jakubowski JA, Bourguet N, Boulay-Moine D, Sugidachi A, Yamaguchi S, Barragan P, Zhou C, Moulard M.

Thromb Haemost. 2012 Feb;107(2):388-95. doi: 10.1160/TH11-04-0282. Epub 2011 Dec 21.

PMID:
22186965
7.

Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activity.

Barragan P, Paganelli F, Camoin-Jau L, Bourguet N, Boulay-Moine D, Moulard M, Bonello L.

Thromb Haemost. 2010 Aug;104(2):410-1. doi: 10.1160/TH10-02-0086. Epub 2010 Jun 29. No abstract available.

PMID:
20589315
8.

Opinions of families, staff, and patients about family participation in care in intensive care units.

Garrouste-Orgeas M, Willems V, Timsit JF, Diaw F, Brochon S, Vesin A, Philippart F, Tabah A, Coquet I, Bruel C, Moulard ML, Carlet J, Misset B.

J Crit Care. 2010 Dec;25(4):634-40. doi: 10.1016/j.jcrc.2010.03.001.

PMID:
20435430
9.

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.

Poignard P, Moulard M, Golez E, Vivona V, Franti M, Venturini S, Wang M, Parren PW, Burton DR.

J Virol. 2003 Jan;77(1):353-65.

10.

Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes.

de Mareuil J, Mabrouk K, Doria E, Moulard M, de Chasteigner S, Oughideni R, van Rietschoten J, Rochat H, De Waard M, Sabatier JM.

Antiviral Res. 2002 Jun;54(3):175-88.

PMID:
12062390
11.

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.

Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6913-8. Epub 2002 May 7.

12.

Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Asensio VC, Maier J, Milner R, Boztug K, Kincaid C, Moulard M, Phillipson C, Lindsley K, Krucker T, Fox HS, Campbell IL.

J Virol. 2001 Aug;75(15):7067-77.

13.

Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loop.

Carlier E, Mabrouk K, Moulard M, Fajloun Z, Rochat H, De Waard M, Sabatier JM.

J Pept Res. 2000 Dec;56(6):427-37.

PMID:
11152302
14.

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.

Moulard M, Decroly E.

Biochim Biophys Acta. 2000 Nov 10;1469(3):121-32. Review.

PMID:
11063880
15.

Selective HIV-1-induced downmodulation of CD4 and coreceptors.

Chenine AL, Sattentau Q, Moulard M.

Arch Virol. 2000;145(3):455-71.

PMID:
10795515
16.

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.

Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J, Zhao L, Olson W, Kwong PD, Sattentau QJ.

J Virol. 2000 Feb;74(4):1948-60.

17.

V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.

Moulard M, Mabrouk K, Martin I, Van Rietschoten J, Rochat H, Sabatier JM.

J Pept Res. 1999 Jun;53(6):647-55.

PMID:
10408339
18.

Processing and routage of HIV glycoproteins by furin to the cell surface.

Moulard M, Hallenberger S, Garten W, Klenk HD.

Virus Res. 1999 Mar;60(1):55-65.

PMID:
10225274
19.

Antibody neutralization of HIV-1 and the potential for vaccine design.

Sattentau QJ, Moulard M, Brivet B, Botto F, Guillemot JC, Mondor I, Poignard P, Ugolini S.

Immunol Lett. 1999 Mar;66(1-3):143-9. Review.

PMID:
10203047
20.
21.

Retroviral envelope glycoprotein processing: structural investigation of the cleavage site

Moulard M, Chaloin L, Canarelli S, Mabrouk K, Darbon H.

Biochemistry. 1998 Jul 7;37(27):9870. No abstract available.

PMID:
9657701
22.

Retroviral envelope glycoprotein processing: structural investigation of the cleavage site.

Moulard M, Chaloin L, Canarelli S, Mabrouk K, Darbon H.

Biochemistry. 1998 Mar 31;37(13):4510-7. Erratum in: Biochemistry 1998 Jul 7;37(27):9870. Challoin L [corrected to Chaloin L].

PMID:
9521771
23.

HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.

Ugolini S, Moulard M, Mondor I, Barois N, Demandolx D, Hoxie J, Brelot A, Alizon M, Davoust J, Sattentau QJ.

J Immunol. 1997 Sep 15;159(6):3000-8.

PMID:
9300725
24.
25.
26.

Structure of the phenylalanine hydroxylase gene in Drosophila melanogaster and evidence of alternative promoter usage.

Ruiz-Vázquez P, Moulard M, Silva FJ.

Biochem Biophys Res Commun. 1996 Aug 5;225(1):238-42.

PMID:
8769124
27.

Purification and characterization of the nuclease NucM of Erwinia chrysanthemi.

Moulard M, Condemine G, Nasser W, Robert-Baudouy J.

Biochim Biophys Acta. 1995 Jun 9;1262(2-3):133-8.

PMID:
7599187
28.

Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.

Moulard M, Achstetter T, Kieny MP, Montagnier L, Bahraoui E.

Eur J Biochem. 1994 Oct 15;225(2):565-72.

29.

Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.

Moulard M, Montagnier L, Bahraoui E.

FEBS Lett. 1994 Feb 7;338(3):281-4.

30.
31.

Characterization of the nucM gene coding for a nuclease of the phytopathogenic bacteria Erwinia chrysanthemi.

Moulard M, Condemine G, Robert-Baudouy J.

Mol Microbiol. 1993 May;8(4):685-95.

PMID:
8332061
32.

Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism.

Mabrouk K, Moulard M, Gluckman JC, Romi R, Rochat H, Van Rietschoten J, Bahraoui E.

Mol Immunol. 1993 Apr;30(5):503-12.

PMID:
8464430
33.

Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV-1).

Benjouad A, Mabrouk K, Moulard M, Gluckman JC, Rochat H, Van Rietschoten J, Sabatier JM.

FEBS Lett. 1993 Mar 15;319(1-2):119-24.

34.

Systematic use of the incomplete factorial approach in the design of protein crystallization experiments.

Abergel C, Moulard M, Moreau H, Loret E, Cambillau C, Fontecilla-Camps JC.

J Biol Chem. 1991 Oct 25;266(30):20131-8.

35.

Crosslinking of Dam methyltransferase with S-adenosyl-methionine.

Wenzel C, Moulard M, Løbner-Olesen A, Guschlbauer W.

FEBS Lett. 1991 Mar 11;280(1):147-51.

36.

Further studies on the human pancreatic binary complexes involving procarboxypeptidase A.

Moulard M, Michon T, Kerfelec B, Chapus C.

FEBS Lett. 1990 Feb 12;261(1):179-83.

37.

Identification of a procarboxypeptidase A-truncated protease E binary complex in human pancreatic juice.

Moulard M, Kerfelec B, Mallet B, Chapus C.

FEBS Lett. 1989 Jul 3;250(2):166-70.

Supplemental Content

Loading ...
Support Center